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Purpose: Retinal degeneration has been associated with iron accumulation in age-related macular degeneration (AMD),
and in several rodent models that had one or several iron regulating protein impairments. We investigated the iron
concentration and the protective role of human transferrin (hTf) in rd10 mice, a model of retinal degeneration.
Methods: The proton-induced X-ray emission (PIXE) method was used to quantify iron in rd10 mice 2, 3, and 4 weeks
after birth. We generated mice with the β-phosphodiesterase mutation and hTf expression by crossbreeding rd10 mice
with TghTf mice (rd10/hTf mice). The photoreceptor loss and apoptosis were evaluated by terminal deoxynucleotidyl
transferase dUTP nick end labeling in 3-week-old rd10/hTf mice and compared with 3-week-old rd10 mice. The
neuroprotective effect of hTf was analyzed in 5-day-old rd10 mice treated by intraperitoneal administration with hTf for
up to 25 days. The retinal hTf concentrations and the thickness of the outer nuclear layer were quantified in all treated
mice at 25 days postnatally.
Results: PIXE analysis demonstrated an age-dependent iron accumulation in the photoreceptors of rd10 mice. The rd10/
hTf mice had the rd10 mutation, expressed high levels of hTf, and showed a significant decrease in photoreceptor death.
In addition, rd10 mice intraperitoneally treated with hTf resulted in the retinal presence of hTf and a dose-dependent
reduction in photoreceptor degeneration.
Conclusions: Our results suggest that iron accumulation in the retinas of rd10 mutant mice is associated with photoreceptor
degeneration. For the first time, the enhanced survival of cones and rods in the retina of this model has been demonstrated
through overexpression or systemic administration of hTf. This study highlights the therapeutic potential of Tf to inhibit
iron-induced photoreceptor cell death observed in degenerative diseases such as retinitis pigmentosa and age-related
macular degeneration.
All cells require iron for survival and as a cofactor of a
variety of enzymes [1]. Ferrous iron (Fe2+) reacts with H2O2
in the Fenton reaction to produce the highly reactive hydroxyl
radical, which can damage proteins, lipids, and nucleic acids.
Iron retinal homeostasis is regulated by proteins involved in
iron import (transferrin [Tf], transferrin receptor), storage
(ferritin) and export (ceruloplasmin, ferroportin, hephaestin),
thus preventing deleterious consequences of either iron
overload or deficiency. The study of the iron metabolism in
rodent retinas has been partially elucidated by the localization
of iron in the different retinal layers and by the determination
of the various proteins involved in its homeostasis [2,3]. Tf is
mainly expressed in the retinal pigmented epithelium (RPE)
and in photoreceptors (PRs). Tf receptor and ferritin are
present in all outer retinal layers [2]. Ceruloplasmin,
hephaestin, and hepcidin have also been identified in retinas
[4,5].
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Diseases such as aceruloplasminemia and age-related
macular degeneration (AMD) are associated with increased
intraocular iron levels, which contribute to oxidative injury
and subsequent retinal degeneration [6-8]. In fact, iron is
found to be increased in the RPE, Bruch's membrane, and PR
layers from AMD patients [9]. In addition, maculas of the eyes
from patients with geographic atrophy also have shown
elevated levels of Tf, ferritin, and ferroportin in the PRs and
along the internal limiting membrane [10,11].
Iron retinal accumulation is found in rodent models of
retinal degeneration caused by retinal gene mutation. In Royal
College of Surgeons (RCS) rats, with disruption of Mertk
tyrosine kinase receptor, iron accumulation in PR segments is
accompanied by Tf degradation [12]. Rd10 mice present
retinal degeneration caused by mutation in exon 13 of the β-
subunit of the rod phosphodiesterase (βPDE) gene [13,14].
Recently, Deleon E. et al. [15] showed increased expression
of Tf, ceruloplasmin, ferritin, and Tf receptor, and increased
levels of total retinal iron and ferritin-bound iron in rd10 mice.
Tf is an extracellular protein, which has a central role in
iron homeostasis by binding and transferring iron within and
across tissues. Moreover, Tf by its capacity to chelate iron may
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protect the retina from the potentially toxic effects of unbound
iron. In transgenic mice (Tg) carrying the complete human Tf
(hTf) gene (TghTf mice), hTf mRNA has been found in
hepatocytes, oligodendrocytes, and Sertoli cells of the testis
[16,17]. We previously found that in these Tg mice, hTf was
produced predominantly in the RPE and Müller glial cells
(MGCs), as in human retinas, and protected MGCs in primary
culture against iron excess [18].
Here, we studied the iron accumulation during the course
of retinal degeneration in rd10 retinas by the proton-induced
X-ray emission (PIXE) technique. We crossbred rd10 mice
with TghTf mice to create mice with the βPDE mutation and
hTf expression (rd10/hTf mice). To analyze the potential
neuroprotective effect of hTf expression in these mice, we
quantified the PR loss and revealed apoptosis in 3-week-old
rd10/hTf mice, as compared to 3-week-old Rd10 mice. To
confirm the results found in rd10/hTf mice, we performed
intraperitoneal (i.p.) injections of hTf in 5-day-old rd10 mice
and during the three following weeks. We measured the hTf
concentration in the retinas of the injected mice and
determined the outer nuclear layer (ONL) integrity by
measuring the thickness of the PR nuclei layer 20 days after
birth.
METHODS
Proton-induced X-ray emission experiments–animal
specimens: Rd10 mice (a gift from Jeff Boatright Ph.D.,
Department of Ophthalmology, Emory University School of
Medicine, Atlanta, GA) and C57Bl/6J control mice 2–4 weeks
old were fed with a standard laboratory diet and tap water ad
libitum and maintained on 12h:12h light-dark cycle in a
temperature-controlled room at 21–23 °C. All experimental
procedures were performed in accordance with the
Association for Research in Vision and Ophthalmology
Statement for the Use of Animals in Ophthalmic and Vision
Research. Mice were sacrificed by carbon dioxide inhalation
or by an overdose of sodium pentobarbital (Sanofi Santé
Animale, Libourne, France).
Sample preparation: Cryo-sections of 20 µm thickness were
obtained with a cryomicrotome (Leica, Rueil-Malmaison,
France). Sagittal sections close to the optic nerve were
collected on aluminum holders coated previously with a
Formvar film (Agar Scientific LTD, Stansted, United Kindom
UK), then samples were freeze-dried overnight at −30 °C, and
finally stored in a dessicator over silica gel until analysis. A
precise observation of the samples was made with an optical
microscope (Carl Zeiss, Le Pecq, France) to choose the best-
preserved and best-located zones for analysis.
Analysis: The samples were analyzed with a nuclear
microprobe in Bordeaux-Gradignan [19]. The conditions
were exactly the same as our previous studies [20]. A 2.5 MeV
proton beam of 800–900 pA and 5 µm diameter was used. The
scanned areas were 150×150 µm2. X-rays were detected using
an 80 mm2 Si(Li) solid-state detector (Link Analytical, Gif sur
Yvette, France) and backscattered protons were detected with
a 20 mm2 Si surface barrier detector placed at 135° to the beam
direction. The organic mass of the analyzed samples and their
thickness were calculated from the backscattered spectra
using the RUMPIN code [21]. Iron (Fe), copper (Cu), zinc
(Zn), and potassium (K) concentrations were calculated from
the X-ray intensities with the GUPIX software [22]. Special
attention was paid to the elemental losses induced by proton
beam irradiation of the tissue.
After irradiation, the sections were stained with 1%
toluidine blue or 4’,6 Diamidino-2-phenyl-indole (DAPI,
Sigma, Saint Quentin Fallavier, France) diluted 1:2,000, and
observed with an Aristoplan microscope (Leica) equipped for
fluorescence. The identification of the retinal layers in the
adjacent zones allowed us to recognize them in the irradiated
areas. For each layer, it was possible to get the PIXE and
Rutherford backscattering spectra and then to determine the
element concentrations. Data were expressed in µg/g dry
weight tissue ± standard error.
Generation of rd10/hTf mice: Rd10/hTf mice were generated
from rd10 mice (βPDE−/−) and from transgenic mice carrying
the human transferrin gene (TghTf), both with the same
genetic background (C57Bl/6J). TghTf mice carry the long
hTf gene (80 kb) comprising its long 5′- and 3′-regulatory
sequences and its own promoter [23]. Briefly, rd10 mice were
crossbred with TghTf mice (hTf+) to produce heterozygous
rd10/hTf mice (βPDE+/−/hTf+). Enzyme-linked
immunosorbent assay (ELISA) assay permitted screening for
the presence of hTf in the blood, but not for the number of
copies. Heterozygous rd10/hTf mice were then crossbred with
rd10 mice; only generated βPDE−/−/hTf+ mice were selected.
βPDE−/−/hTf+ mice were then crossbred together for five
subsequent generations. βPDE−/−/hTf+ mice were named
rd10/hTf. To control that the crossbreeding had not affected
the process of retinal degeneration observed in rd10 mice, we
also crossbred rd10 mice with wild-type (WT) C57Bl/6J mice
(Janvier, Le Genest St Isle, France). Generated mice, named
rd10/WT, had the βPDE mutation, but did not express hTf. To
check the absence or presence of the mutated βPDE gene, PCR
of DNA was performed from tail biopsies. DNA was extracted
using a DNeasy Blood and Tissues kit column (Qiagen,
Courtaboeuf, France). The primers were as follows (Jeff
Boatright, Emory University, personal communication,
2008): rd10 forward: (5′-TCT CAG CCC ACA ATC TCT
CT-3′); rd10 reverse: (5′-AAA CTT CCC AAA TTC CAG
GT-3′).
PCR: The corresponding PCR amplification was performed
in 35 cycles by denaturation at 95 °C for 15 min; annealing at
94, 55, and 72 °C, respectively, for 30 s, 30 s, and 2 min, and
elongation at 72 °C for 10 min. The product obtained was
purified and digested with the enzyme HhaI (Invitrogen,
Cergy Pontoise, France), whose restriction site is not included
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in the rd10 mutant DNA [13]. After 1 h incubation with the
enzyme at 37 °C, the digested DNA was run on an agarose gel
for separation of short DNA fragments. The homozygous rd10
mutation was revealed by the presence of bands having the
sizes of 1,257 and 715 bp; the heterozygous mutation was
revealed by the 1,257, 715, 661, and 54 bp bands; and no
mutation was revealed by the 1,257, 661, or 54 bp bands.
Human transferrin injection: Five-day-old rd10 mice were
intraperitoneally injected daily for 20 days, with Ca2+-free
physiologic buffer (buffer saline sodium [BSS]) or with
human apotransferrin solution (Sigma) at concentrations of 6,
12, 24, and 48 mg/ml in BSS. During the first 7 days, mice
received 0.1 ml of hTf solution. The following 7 days, they
received 0.2 ml and after, up to the date of sacrifice; the
volume of injections was 0.3 ml. Mice were sacrificed at 25
or 47 days postnatally for histological analysis and hTf
quantification in neural retina and immunohistochemistry
studies.
Human transferrin quantification: Mice were perfused
through the left cardiac ventricle with 1× phosphate buffer
saline (PBS). Five mg of neural retinas were incubated in lysis
buffer (15 mM Tris, pH 7.9; 60 mM KCl; 15 mM NaCl; 2 mM
EDTA; 0.4 mM phenylmethylsulphonyl fluoride [PMSF;
Perbio Science, Brebiers, France]). After four freeze–thaw
cycles, lysates were centrifuged at 5,000× g for 10 min, and
supernatants were stored at −20 °C. hTf was quantified by an
antibody-sandwich ELISA using, as previously described,
two different polyclonal antibodies directed against hTf:
sheep anti-hTf (Biodesign, distributed by Invitrogen) and
rabbit anti-hTf (Florian Guillou, INRA, Tours-Nouzilly,
France) [24]. The minimum limit for hTf detection was 0.1
ng/ml. The cross-reaction rate for hTf antibodies with mouse
Tf was less than 0.05%. All standards and samples were
assayed in triplicate. Results were reported in ng/ml of
supernatant.
Histology: Enucleated eyes from mice were fixed with 4%
paraformaldehyde, 0.5% glutaraldehyde (LADD, Inland
Europe, Conflans-sur-Lanterne, France), in PBS for 2 h. After
fixation, samples were washed, dehydrated, and transferred
into the infiltration solution of the Leica historesin embedding
kit overnight at 4 °C. Samples were embedded in the
embedding medium (Leica) and attached to a block holder
after polymerization. Plastic sections (5 µm thick) were
prepared on a microtome (Leica), stuck on slides coated with
gelatin and stained 2 min with 1% toluidin blue solution.
Sections were observed with an Aristoplan microscope
(Leica) and photographed with a camera (Leica).
Measurement of nuclear layer thicknesses: For comparison of
retinal morphology from 3-week-old rd10, rd10/WT, and
rd10/hTf mice, and for comparison of BSS- and hTf-injected
25-day-old rd10 mice, the outer nuclear layer (ONL) and inner
nuclear layer (INL) thicknesses were measured in sagittal
sections made every 200 µm on both sides of the optic nerve
(at the inferior and superior poles) and across the whole retina.
For each protocol, the ONL measurements were made with
Visilog 6.2 (Noesis, Courtaboeuf, France) in three different
sections close to the optic nerve from three to six eyes, and
averaged out to a single value.
Immunohistofluorescence analysis: Freshly enucleated eyes
were fixed for 2 h with 4% paraformaldehyde in 1× PBS Gibco
(Invitrogen), washed with PBS, mounted in Tissue-Tek
O.C.T. (Siemens Medical, Puteaux, France) and frozen with
dry ice. Frozen sections (10 µm) were cut on a microtome
(Leica). Sections were incubated for 1 h with different primary
antibodies diluted in PBS: rabbit polyclonal anti-mouse Tf
(1:100; F. Guillou), rabbit polyclonal anti-hTf, (1:100, F.
Guillou), anti-rhodopsine (1:200; Rho4D2, a gift from Dr.
Robert S. Molday, University of British Colombia). Negative
control sections were incubated with rabbit non-immune
serum (Gibco) or without primary antibodies. After washing
with PBS, sections were incubated for 1 h with secondary
antibodies (goat anti-rabbit), labeled with Texas Red (Jackson
Laboratories; distributed by TebuBio, Le Perray en Yvelines,
France) or Alexa 488 (Molecular Probes; distributed by
Invitrogen), both diluted 1:200 in PBS. Cones were directly
labeled with peanut agglutinin conjugated with fluorescein
isothiocyanate (Sigma). Nuclei were counterstained with
DAPI. Labeled sections were observed under an
epifluorescence microscope (Olympus, Rungis, France) and
photographed with an Olympus camera using identical
exposure parameters across samples to be compared.
Terminal deoxynucleotidyl transferase dUTP nick end
labeling: The terminal deoxynucleotidyl transferase-
mediated biotinylated UTP nick end labeling (TUNEL)
reaction was performed, along with DAPI staining. The
protocol was adapted from manufacturer’s protocol (Roche
Diagnostics, Meylan, France). Briefly, frozen retinal sections,
obtained as described above, were fixed for 10 min with
paraformaldehyde, washed with PBS 1×, and incubated for 2
min with 0.1% Triton X-100 in 0.1% sodium citrate on ice.
Then, sections were incubated for 60 min at 37 °C with the
reaction mixture (TUNEL enzyme plus TUNEL label [1/9]),
and finally, nuclei were counterstained with DAPI.
Statistical analysis: Statistical analysis was conducted using
the Student’s t test. A p value <0.05 was considered
statistically significant. Measurements of retinal nuclear layer
thicknesses from various groups were compared with two-
way ANOVA (ANOVA). Analysis was performed using
GraphPad Prism 4 software. Each experimental condition was
repeated three to four times on three to six samples each time.
All results are presented as mean±standard error of the mean
(SEM).
RESULTS
Proton induced X-ray emission analysis of iron distribution
in rd10 mouse retinas: Iron, copper, zinc, and potassium ion
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Figure 1. Proton-induced X-ray emission (PIXE) microanalysis of iron and potassium in 2-, 3-, and 4-week-old rd10 and wild-type mouse
retinas. A-B: Concentrations in μg/g dry weight of potassium (A) and iron (B) correspond to area of photoreceptor segments from 2-, 3-, and
4-week-old rd10 and wild-type (WT) mouse retinas. White bar represents WT mice and black bar rd10 mice. Values were means±SEM (n=7–
11; *p<0.05, ** p<0.01, *** p<0.001; ns: not significant). C-F: Bidimensional maps represent potassium (C, E) and iron (D, F) distribution
in 4-week-old WT (C-D) and rd10 (E-F) mice. Concentrations, expressed in counts per pixel, increase according to the color scale, from white
to black. The different retinal layers were identified after staining with toluidine blue and are outlined with dotted lines. Dimension of the
scan are 150×150 μm2. Abbreviations: ch is choriocapillaris; inl is inner nuclear layer; ipl is inner plexiform layer; is is inner segments of
photoreceptors; onl is outer nuclear layer; opl is outer plexiform layer; os is outer segments of photoreceptors; rpe is retinal pigmented
epithelium; sc is sclera.
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contents were analyzed by PIXE microanalysis in retinas from
rd10 mice and WT mice. Analysis was performed at 2, 3, and
4 weeks of age to capture early, peak, and late stages of
degeneration, respectively. Potassium content was the same
in both rd10 and WT mice and did not change with age
between 2 and 4 weeks (Figure 1A,C,E). Total iron (heme and
non-heme) content analysis demonstrated a significant
increase in the area corresponding to PR inner and outer
segments in rd10 mouse retinas, compared to WT mice at all
ages studied. Retinal iron levels in rd10 mice compared with
age-paired controls increased between 1.71, 2.45, and 3.15
fold in 2-, 3-, and 4-week-olds, respectively. Moreover, iron
accumulation in the outer neural retinas of rd10 mice
significantly increased in a time-dependent manner (by 23%
between 2 and 3 weeks and by 51% between 3 and 4 weeks),
whereas in WT mice, it remained at the same level (Figure
1B,D,F). Zinc and copper content was also significantly
higher in the same area in rd10 mice compared with same-age
controls. In rd10 mouse retinas, zinc increase was age-
dependent, whereas copper content was statistically higher
only between 3 and 4 weeks (Figure 2). Thus, PIXE analysis
demonstrated that iron content, as well as zinc and copper
content, was higher in rd10 mice compared to WT mice.
Analysis of rd10/hTf mice–hTf expression: We generated
rd10/hTf and rd10/WT mice by crossbreeding rd10 mice with
TghTf mice or WT mice. As seen in Figure 3A, genotyping
allows detection of the βPDE mutation. We quantified the
concentration of hTf in the neural retinas of 3-week-old rd10,
rd10/WT, and rd10/hTf mice, and compared the results with
those from TghTf mice. As expected, there was no hTf
expression in rd10 and rd10/WT mouse eyes. In neural retinas,
the hTf concentration in rd10/hTf mice was similar to that in
TghTf mice (Figure 3B). These results were confirmed by
immunodetection of hTf in retinal sections of the four types
of mice. hTf staining was not observed in retinas of rd10 mice
(Figure 3D) similarly to the control incubated with no immune
serum (Figure 3C) and rd10/WT mice (data not shown). hTf
was localized in rd10/hTf mice (Figure 3E) in the same layers
previously described in TghTf mouse retinas, that is,
astrocytes, MGCs, INLs, outer and inner plexiform layers,
inner segments, and the RPE [18]. Immunodetection of
cellular retinaldehyde binding protein (CRALBP), a specific
marker for MGCs, allowed the observation that hTf was
located in MGC bodies within the inner nuclear layer and in
MG cell processes that formed radial extensions through the
retina (Figure 3F). Mouse Tf was detected in the same layers
in rd10 and rd10/hTf mice (Figure 3G,H). The staining was
slightly higher in inner segments, inner nuclear layers, and
ganglion cell layers of rd10/hTf mice, compared to rd10 mice.
Retinal degeneration: We have considered retinal
degeneration at the peak of degeneration for rd10 mice,
corresponding to 3-week-old rd10, rd10/WT, and rd10/hTf
mice (Figure 4). We analyzed PR loss and inner retina
modifications by measuring ONL and INL thickness,
respectively. As expected, no differences in ONL thickness
were found between rd10 and rd10/WT mice (Figure
4A,B,D). However, the ONL thickness was significantly
preserved in rd10/hTf mice compared to rd10 or rd10/WT
mice (Figure 4C,D). This difference was only statistically
significant in the inferior pole. From 400 µm to 2000 µm in
the inferior pole, ONL thickness in rd10/hTf mice was 2.6-
fold higher than in the two controls, rd10 and rd10/WT mice
(Figure 4D). Average ONL thickness in the superior and
inferior poles in 3-week-old TghTf mice was 43.9 µm (data
not shown; SEM±0.56). It was not different in C57Bl/6J wild-
type mice. In rd10/hTf mice, average ONL thicknesses in the
superior and inferior poles were 59% and 36% lower (p<0.001
for the superior pole and p<0.05 for the inferior pole,
respectively), in comparison with TghTf mice (data not
shown).
Figure 2. Proton-induced X-ray emission (PIXE) microanalysis of
zinc and copper in 2-, 3-, and 4-week-old rd10 and wild-type mouse
retinas. Concentrations of zinc (A) and copper (B) in μg/g dry weight,
correspond to photoreceptor segments area from 2-, 3-, and 4-week-
old rd10 and wild-type (WT) mouse retinas. The white bar represents
WT mice and the black bar rd10 mice. Values were means±SEM
(n=4–7; p<0.05, ** p<0.01, *** p<0.001; ns: not significant).
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In the INL at the superior pole, there was no significant
difference between rd10, rd10/WT, and rd10/hTf mice.
However, INL thickness at the inferior pole for rd10/hTf was
1.3 and 1.5 times higher than in rd10 mice and rd10/WT mice,
respectively (Figure 4E). No significant differences were
found between the INL thicknesses in the two poles in rd10/
hTf and TghTf mice (data not shown).
We also detected apoptosis in PR nuclei by the TUNEL
method in 3-week-old rd10, rd10/WT, rd10/hTf, and TghTf
mice (Figure 4F-M). In the medial portion of the inferior pole,
many PR nuclei in apoptosis in rd10 and rd10/WT mice were
observed (Figure 4F,H), whereas only a few TUNEL-positive
PR nuclei were detected in rd10/hTf mice, and none were
detected in TghTf mouse retinas (Figure 4J,L).
The distribution and the morphology of cones and rods
were analyzed by immunohistofluorescence in retinal cross-
sections of all types of studied mice. Rd10 and rd10/WT
mouse cones labeled with peanut agglutinin seemed to be
sparse, globular with collapsed outer segments (OSs), thin,
small, and stunted (Figure 5A,B). However, the cones from
rd10/hTf mice were shown to be more elongated and
numerous than in rd10 mice (Figure 5C) and similar to those
of TghTf mice (Figure 5D). On the other hand, rods
immunodetected with Rho4D2 antibodies showed a similar
pattern in both rd10 and rd10/WT mice (Figure 5E,F). The
thickness of rod OSs was more preserved in rd10/hTf mice
than in the two rd10 mice (Figure 5G). hTf expression in rd10/
hTf mice seemed to protect the two types of PRs, but rods
were especially protected.
Human transferrin injection of rd10 mice–hTf retinal content:
We tested the potential protective role of hTf on retinal
degeneration, by daily intraperitoneal injection into 5-day-old
rd10 mice of four different concentrations (6, 12, 24, and
48 mg/ml) of hTf. We determined whether, after i.p. injection,
hTf could cross the blood-retinal barrier and reside within the
retina. The concentration of hTf was quantified by ELISA in
neural retinal lysates 20 days after the beginning of daily
injections, which corresponded roughly to the concentration
3 weeks postnatally and to the peak of major retinal
degeneration in rd10 mice. A dose-dependent effect between
the quantity of injected hTf and the local hTf concentration
was found in the retina, with a plateau reached after injecting
with 24 mg/ml (Figure 6A). In rd10 mice injected with 48 mg/
ml of hTf, hTf staining was observed in retinal vessels and
choriocapillaries (compare Figure 6B with Figure 3D). Mouse
Tf was present throughout the retina and strongly localized in
the ganglion cell layer, at the inner top of the inner nuclear
layer, in the outer plexiform layer, and in the inner segment
(Figure 6C).
Retinal degeneration: The neuroprotective capacity of hTf
was determined by measuring the ONL and the INL thickness
every 200 μm on the totality of superior and inferior poles in
the retinas of rd10 mice injected with vehicle (BSS) or hTf
solutions at 24 and 48 mg/ml. As we observed in the retinal
sections from 25-day-old rd10 mice treated with BSS and
stained with toluidin blue, the ONL completely disappeared,
and only one to two rows of PR nuclei remained close to the
RPE layer (Figure 7A). The treatment with 24 mg/ml and in
major degree with 48 mg/ml of hTf rescued the overall
structure, demonstrated by the length of the OS as well as the
density of rod nuclei (or the ONL thickness; Figure 7B-C). A
precise analysis of nuclear layer thickness in animals treated
with 24 mg/ml of hTf illustrated that the ONL was preserved
in the major part of the retina. However, it was preserved
statistically more significantly both between 400 and 800 µm
at the superior pole (on average, it was 2.5 fold higher in mice
injected with 24 mg/ml hTf than those injected with BSS) and
between 800 and 2,000 µm at the inferior pole (on average,
twofold higher in mice injected with 24 mg/ml hTf than those
injected with BSS; Figure 7D). In rd10 mice injected with
48 mg/ml of hTf, the ONL thickness was significantly higher,
between 6.3 and 3.7 fold, at the superior and inferior poles,
respectively, than in rd10 mice injected with BSS (Figure 7D).
The ONL thickness of rd10 mice injected with 48 mg/ml of
hTf was not statistically different from the ONL in the two
poles in TghTf mice (data not shown).
Analysis of the INL revealed that the superior pole shows
the same pattern of retinal thickness in rd10 mice injected with
BSS or with 24 mg/ml of hTf, but it was much higher in the
inferior pole. By contrast, the INL thickness of rd10 mice
injected with 48 mg/ml of hTf showed a pattern thicker in both
poles than did that of mice injected with BSS (Figure 7E).
There was no difference between the mean INL thickness of
rd10 mice injected with 48 mg/ml hTf and TghTf mice (data
not shown).
These results were confirmed by PR apoptosis detection
in retinal sections of rd10 mice injected with BSS or with hTf,
and evaluated by TUNEL reaction. We detected many PR
nuclei in apoptosis in the ONL of rd10 mice injected with BSS,
whereas in hTf injected rd10 mice, only a few apoptotic
(TUNEL positive) nuclei were found (Figure 7F-K). Injection
of hTf had a protective effect on retinal degeneration, by
reducing the loss of PRs by apoptosis.
Finally, we determined the hTf effects on PR cell rescue
in rd10 mutant mice injected with BSS or with two different
hTf doses (24 and 48 mg/ml). We observed that cones from
rd10 mice injected with BSS were round and disorganized,
similar to the non-injected rd10 mice (compare Figure 8A with
Figure 5A,B). However, in rd10 animals injected with hTf, as
in rd10/hTf or TghTf mice, the cones were elongated and more
numerous than in rd10 mice injected with BSS (compare
Figure 8B,C with Figure 5C,D). On the other hand, rods in
rd10 mice injected with BSS also showed pathological
characteristics of rod degeneration similar to the rods from
rd10 or rd10/WT animals (compare Figure 8D with Figure
5E,F). However, in those rd10 mice injected with hTf, the
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Figure 3. Characterization of human transferrin (hTf) expression in rd10/ hTf mouse. A: Gel migration of DNA extracted from products of
rd10 or rd10/hTf (lane 1), TghTf (lane 2), and rd10+/−hTf (lane 3) mice use to establish the genotypes. The homozygous rd10 mutation was
revealed by the presence of 1257 and 715 bp bands. The heterozygous mutation had 1257, 715, 661, and 54 bp bands. The wild-type (WT)
had 1257, 661, and 54 bp bands. Bands 54 bp in size are not visible on the gel. B: Enzyme-linked immunosorbent assay was used to quantified
hTf concentrations in lysats of neural retinas of rd10, rd10/WT, rd10/hTf, and TghTf mice. Values were means±SEM n=12; ns means not
significant. C-F: hTf was immunolocalized on frozen sections of 3-week-old rd10 (D) and rd10/hTf (E) mouse retinas. Non-immune serum
was used as a control (C). TghTf mouse retina was labeled with anti-CRALBP, a specific marker for Müller glial cell (F). G-H: Mouse Tf
was immunolocalized on frozen sections of 3-week-old rd10 (G) and rd10/hTf (H) mouse retinas. Abbreviations: Ch is choroid; GCL is
ganglion cell layer; INL is inner nuclear layer; IPL is inner plexiform layer; IS is inner segment; ONL is outer nuclear layer; OPL is outer
plexiform layer; RPE is retinal pigmented epithelium. Scale bars in C-H equal 50 μm.
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Figure 4. Retinal degeneration in 3-week-old rd10 mouse was compared to 3-week-old rd10/wild type (WT) and rd10/human transferrin (hTf)
mice. A-C: Central part of equatorial sections represent histology from 3-week-old rd10 (A), rd10/WT (B), and rd10/hTf (C) mouse retinas.
Nuclei were stained with toluidin blue. D-E: Outer nuclear layer (ONL; D) and inner nuclear layer (INL; E) thickness were measured every
200 μm, along the entirety of retinal sections of rd10, rd10/WT, and rd10/hTf mice at 3 weeks postnatally. (black line) rd10 mice, (red line)
rd10/hTf mice, (gray line) rd10/WT mice. Values represent means±SEM, n=6–8. rd10/hTf mice were compared to rd10 mice: * p<0.05;
**p<0.001; ***p<0.0001; ns represents not significant. rd10/hTf mice were compared to rd10/WT mice (≠≠ p<0.001; ≠≠≠ p<0.0001; ns: not
significant; ON is optic nerve). F-M: Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) was used to stain retinas from
rd10 (F), rd10/WT (H), rd10/hTf (J), and TghTf (L) mice at 3 weeks postnatally. Nuclei were stained with 4’,6 Diamidino-2-phenyl-indole
(DAPI): rd10 (G), rd10 WT (I), rd10/hTf (K), and TghTf (M). Abbreviations: GCL is ganglion cell layer; INL is inner nuclear layer; ONL
is outer nuclear layer; RPE is retinal pigmented epithelium. Scale bars in A-C and F-M equal 100 μm.
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number and the length of rods were clearly higher than in those
mice injected with BSS. The effect was more pronounced in
rd10 mice injected with a dose of 48 mg/ml than in mice
injected with 24 mg/ml of hTf (Figure 8E,F). In rd10 mice
treated with 24 mg/ml of hTf, labeling of rods was similar to
that of rods in rd10/hTf mouse retinas (compare Figure 8E
with Figure 5G). The rod layer from rd10 mice injected with
48 mg/ml of hTf was characteristically similar to that of TghTf
mice (compare Figure 8F with Figure 5H). Thus, high doses
of hTf showed a strong protective effect on rods’ and cones’
outer segments’ integrity.
DISCUSSION
Iron is an essential component of cell survival [1]; however,
its capacity to generate highly reactive hydroxyl free radicals
via the Fenton reaction can result in toxicity for the cells. Iron
overload is found in human retinas during aging [6,25] and
has been associated with retinal degeneration in AMD patients
[9]. Moreover, iron homeostasis defects in
aceruloplasminemia patients [26] or in Cp−/−Heph-/Y mice
[4] are directly associated with retinal degeneration. Two
rodent models of retinal degeneration caused by an inherited
mutation have been demonstrated to present an iron retinal
excess and a modification of iron-regulating protein
expression in RCS rats with a mutation in the Mertk gene and
in rd10 mice with a mutation in the βPDE gene [12,15]. The
rd10 mutant is a phenotype characterized by slow retinal
degeneration; it is a potential model for studying the cell
biology of this disease and for testing therapeutic tools.
Results from the present study using PIXE analyses
showed an alteration in iron metabolism during retinal
degeneration in rd10 mice. These results were similar to those
previously reported in animals evaluated when 3 weeks old
[15]. We detected an increase in total (heme and non-heme)
iron content in inner and outer segments of PRs from rd10
mice, compared to control mice, and its accumulation was
age-dependent. The major part of total iron content may be
bound in ferritin complexes, since Deleon E. et al. [15] found
increased ferritin-bound iron in rd10 mouse retinas. In
addition, our results showed that more than two-thirds of iron
content was localized in the inner segments of PRs; these
contain the metabolic machinery of PRs and mitochondria,
and need iron to be available. Zinc levels were also age-
dependent in the rd10 animals, whereas copper content only
increased between 3 and 4 weeks postpartum. Zinc, like iron,
is found in sub-RPE deposit formations in AMD patients, and
it is abundant in RCS rats [9,27,28]. Human copper
metabolism disorders such as Menkes disease and Wilson
disease can result in retinal degeneration [29].
Our results show that degenerative processes due to
genetic mutations correlate with the increased release of
(bound or unbound) iron after PR death [1,3]. The excessive
iron level in rd10 mice, as well as in human AMD cases,
promotes itself PR death. An altered iron, zinc, and copper
metabolism may play an important role in oxidative stress
associated with the progression of retinal degeneration.
Furthermore, we investigated the potential protective
effect of hTf in the rd10 model of retinal degeneration. We
previously demonstrated, in vitro, that hTf expressed by
MGCs from TghTf mice in culture or hTf added to the culture
medium of MGCs from WT mice, had the same protective
role against oxidative stress induced by iron excess [18]. Our
study, based on these two in vitro methods, was applied in
vivo to rd10 mice: one by generating rd10 mice expressing
hTf and other one by injecting hTf directly into rd10 mice.
For the first strategy, we generated a mouse homozygous
for the βPDE mutation and the hTf gene: the rd10/hTf mouse.
This mouse expressed the same hTf content in retinas as that
in TghTf mice. Moreover, the crossbreeding did not modify
the hTf transgenic construct, because the protein was
localized, as it is in human retinas and in TghTf mouse retinas.
hTf was expressed in the whole retina, especially in the RPE
Figure 5. Rods and cones immunolabeling in 3-week-old rd10, rd10/wild-type (WT), rd10/human transferrin (hTf), and TghTf mice. Cones
(A-D) and rods (E-H) were localized on frozen sections from 3-week-old rd10 (A, E), rd10/WT (B, F), rd10/hTf (C, G), and TghTf (D, H)
mouse retinas. Cones were labeled with peanut-agglutinin coupled with fluorescein isothiocyanate and rods with an antibody against opsin
(Rho4D2). Abbreviations: IS is inner segment; ONL is outer nuclear layer. Scale bars in A-D equal 10 μm; E-H scale bars equal 50 μm.
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and MGCs [18]. The ONL thickness was more preserved and
TUNEL positive cells were less numerous in rd10/hTf mice
than in rd10 mice. In addition, hTf partly preserved the
number of rods and the morphology of cones. Thus, hTf
expression in rd10/hTf, at the level of TghTf mouse retinas,
rescued PRs being lost due to the βPDE mutation. PR death
induced structural changes in neuronal postsynaptic cells,
which resulted in decreased INL thickness [30]. In rd10/hTf
mice, there was a higher INL thickness than in rd10 mice,
demonstrating the hTf neuroprotective effect not only on PRs
but also on the preservation of other neurons. The percentage
of hTf protection was higher in the inferior pole than in the
superior pole, which suggested a gradient-like hTf expression
in rd10/hTf mouse retinas.
For the second strategy, every day we injected 24 and
48 mg/ml of apo-hTf (iron-free hTf) into 5-day-old rd10 mice
before the onset of retinal degeneration. We chose the i.p.
route instead of the intravitreal one to avoid the risks of ocular
infection and variations in intraocular pressure. We noted that
the immunostaining of hTf in mouse retinas injected with hTf
(Figure 5B) was stronger in choroidal and retinal capillaries.
Hunt and Davis [31] demonstrated that Tf from
choriocapillaries can be bound by the RPE on the basal
membrane and released to other side. Human transferrin has
50% homologous to mouse transferrin proteins, so we can
suppose that hTf can be bound by mouse transferrin receptors.
Burdo J.R. et al. [32] demonstrated that the route of iron
delivery throughout the inner blood-retina barrier could
involve Tf receptor-mediated transcytosis. The protective
effect and hTf concentration in retinas were proportional to
the concentration of hTf injected. The effect of hTf injection
was measured 20 days after the beginning of the protocol, at
Figure 6. Retinal human transferrin
(hTf) in rd10 mice intraperitoneally
injected with hTf. A: Enzyme-linked
immunosorbent assay (ELISA) was
used to quantify hTf in lysat of neural
retinas from rd10 mice daily injected
intraperitoneally with 6, 12, 24, and 48
mg/ml of hTf solution from day 5
postnatally and sacrificed at 25 day
postnatally. hTf concentration in rd10
mice injected was compared to hTf
concentration in 3-week-old rd10/hTf
and TghTf mouse retinas. Values were
means±SEM, n=10. Mice injected with
12 mg/ml were compared with mice
injected with 6 mg/ml. Mice injected
with 24 mg/ml were compared with
mice injected with 12 mg/ml. Mice
injected with 48 mg/ml were compared
with mice injected with 24 mg/ml. rd10/
hTf mice were compared with TgTfH
mice (*p<0.05; ** p<0.01; ***
p<0.001; ns: not significant). B: hTf was
immunolocalized on retinal sections of
3-week-old rd10 mice injected with 48
mg/ml of hTf. C: mouse Tf was
immunolocalized on retinal sections of
3-week-old rd10 mice injected with 48
mg/ml of hTf. Abbreviations: Ch is
choroid; GCL is ganglion cell layer; INL
is inner nuclear layer; IS is inner
segment; ONL is outer nuclear layer;
OPL is outer plexiform layer; RPE is
retinal pigmented epithelium; Rv is
retinal vessel. Scale bars in B-C equal
100 μm.
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Figure 7. Retinal degeneration in 3-week-old rd10 mice injected with buffer saline sodium (BSS) or human transferrin (hTf). A-C: Retinal
central sections represent histology of 25-day-old rd10 mice injected with BSS (A) or 24 mg/ml (B) and 48 mg/ml of hTf (C). Nuclei were
stained with toluidin blue. D-E: Outer nuclear layer (ONL; D) and inner nuclear layer (INL; E) thickness were measured every 200 μm, along
the whole retinal section from 5-day-old rd10 mice daily injected intraperitoneally with BSS and 24 and 48 mg/ml of hTf, and sacrificed at
25 days postnatally. (black line) rd10 mice injected with BSS, (light gray line) rd10 mice injected with 24 mg/ml of hTf, (dark gray line) rd10
mice injected with 48 mg/ml of hTf. Values represent means±SEM, n=5–8. D: rd10 mice injected with 24 mg/ml of hTf were compared to
mice injected with BSS: * p<0.05; **p<0.001; ***p<0.0001; ns represent not significant. rd10 mice injected with 48 mg/ml of hTf were
compared to mice injected with BSS: ***p<0.0001. rd10 mice injected with 48 mg/ml of hTf were compared to mice injected with 24 mg/ml
of hTf: ≠ p<0.05; ≠≠ p<0.001; ≠≠≠ p<0.0001; ns: not significant. E: The differences are mainly insignificant (ON: optic nerve). F-K: Terminal
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) was used to stain retina from mice intraperitoneally injected every day since
day 5 with BSS (F), or with 24 mg/ml of hTf (H) and 48 mg/ml (J) of hTf, and sacrificed at 25 days postnatally. Nuclei were stained with 4’,
6 Diamidino-2-phenyl-indole (DAPI) on retinal sections from rd10 mice injected with BSS (G), 24 (I) and 48 mg/ml (K) of hTf. Abbreviations:
GCL is ganglion cell layer; INL is inner nuclear layer; ONL is outer nuclear layer; RPE is retinal pigmented epithelium. Scale bars in A-C
and F-K equal=100 μm.
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25-day-old, the peak of retinal degeneration in rd10 mice
[30]. When 24 and 48 mg/ml were injected, the hTf
concentration in retinas was nearly the same as that in rd10/
hTf and TghTf mice. However, the retinas of rd10 mice
injected with 48 mg/ml of hTf had kept almost all their PRs,
compared to rd10 mice injected with BSS. The ONL thickness
was nearly the same as that in TghTf and WT mice. The retinas
of these animals showed only few TUNEL-positive PRs, and
the cone and rod morphology was intact. Moreover, the INL
thickness was similar at the INL in TghTf mice, demonstrating
the preservation of secondary neurons. But in rd10 mice
injected with 24 mg/ml, the PR rescue was less substantial
than in 48 mg/ml hTf-injected mice. Nevertheless, the rescue
of PRs was significant, compared to that in mice injected with
BSS. The discrepancy in the ONL thickness rescue and the
hTf concentration measured in retinas of rd10 mice injected
with 24 and 48 mg/ml, could be explained by a limited
quantity of Tf that could be present in the retina. The rest of
the hTf remained available in the blood flow for the retina. A
regulatory mechanism may exist to regulate Tf entry to retinas
[33].
There was a discrepancy between the almost equal levels
of hTf in the retinas of rd10/hTf mice or mice injected with
hTf and the different level of PR protection. This might be
explained by the limited capability of retinal cells (in which
are located the RPE and MGCs) to produce hTf in rd10/hTf
mice while the blood concentration of hTf in injected mice
was elevated, available, and could be regulated.
The two strategies permitted presence of hTf in the retinas
of mice and reduced retinal degeneration. In rd10 mouse
retinas, PR death produced oxidative stress and released iron
[15,34]. Deleon et al. [15] demonstrated that levels of Tf,
ceruloplasmin, ferritin, and Tf receptor increased in 3-week-
old rd10 mouse retinas. Thus, in response to iron excess, rd10
retinas increase Tf expression to manage and transport iron.
In our study, we experimentally increased Tf levels, but to a
higher level than is normal for rd10, to achieve an amount
sufficient both to chelate and decrease the iron released and
to decrease oxidative stress. hTf has already been studied for
its potential as antioxidant. In renal ischemia-reperfusion
injuries, Tf lowers the circulating redox-active iron levels
[35]. Tf has potent anti-apoptotic/cytoprotective effects
against Fas-mediated signals in hepatocytes and
lymphohematopoietic cells [36,37]. In a rabbit model of
cataracts formed after cataract surgery, Tf synthesis
upregulated in lens epithelia, acting as a survival and
proliferative factor [38].
Here, we also observed that in rd10/hTf mice and in rd10
mice injected with hTf, mouse Tf staining increased in the
retina, especially in the inner segment and ganglion cell layer,
compared to the rd10 mouse retina (Figure 2H and Figure 5C).
This data confirmed our previous study [18], where we
demonstrated that hTf expression in TgTfH transgenic mice
increased mouse Tf expression, and enhanced a possible loop
of autoregulation for transferrin expression similar to that in
the two mouse species studied here.
The present study shows that hTf, an endogenous iron-
binding protein, preserves rods and cones, which have been
demonstrated to be highly sensitive to iron excess [39]. hTf
also protected secondary neurons, and thus possibly preserved
neuronal post-synaptic connections. Other iron homeostasis
proteins, like heavy chains of ferritin, can also participate in
the control of iron excess, as we have shown recently for aging
and light-induced stress to retinas of heterozygous mice with
a heavy chains of ferritin (Picard E. et al., IOVS, in press).
These results show that one of the major central actors in many
neuronal degenerative diseases in the eye, as in the brain, is
the ability of free iron to generate free radicals and be a major
Figure 8. Rods and cones distribution in 3-week-old rd10 mice injected with buffer saline sodium or human transferrin. Cones (A-C) and rods
(D-F) were localized on frozen sections from mice daily intraperitoneally injected with BSS (A, D) or 24 mg/ml (B, E), and 48 mg/ml (C,
F) of hTf since day 5 and sacrificed at 25 days postnatally. Cones were labeled with peanut-agglutinin coupled with fluorescein isothiocyanate
(FITC), and rods with antibodies against rhodopsin (Rho4D2). Abbreviations: IS is inner segment of the photoreceptors; ONL is outer nuclear
layer. Scale bars in A-C equal 10 μm; in D-F they equal 50 μm.
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part of the oxidative stress mechanism. How long such a
treatment needs to be pursued to protect cones in the long-term
remains to be determined, but it is already known that Tf is
not toxic by itself at a high dose and when administrated over
a long period. Preliminary experience demonstrates the
limited role of hTf in protecting retinas over 47 days
postnatally (data not shown). Is this oxidative stress
mechanism also involved in the protection of interneurons
(amacrin, bipolar, and horizontal cells) between PN0 and
PN15 from programmed cell death during the development of
the mouse retina? How do neurotrophic actors, like CNTF or
FGF, interact with these iron-dependent oxidative
mechanisms? This is under investigation. Tf also has multiple
biologic functions not related to its iron binding capacity, but
rather to other properties, such as its ability to bind insulin-
like growth factor binding protein 3 [40]. With the use of a
biologic agent like hTf, we could override the potential use of
pharmaceutical chelators, such as deferoxamine, which are
toxic at high doses, or of other chelators that have been
proposed to protect retinas [41]. In this study, we found a
correlation of iron homeostasis imbalance with the
neurodegenerative state of retinas in rd10 mice, and showed,
for the first time, a protective role for hTf in an animal model
accumulating iron in PRs. Iron accumulation due to retinal
degeneration was previously found in RCS rats and in AMD
patients. Thus, it can be proposed that iron released after cell
metabolism impairment, due for instance to a deficient
phagocytosis, or cell death [1,3], will participate in a common
toxic mechanism that is involved in degenerative diseases.
This therapeutic strategy could be applicable to other
degenerative models. We proposed that in RCS rats the
defective phagocytosis disturbed iron recycling and resulted
in Tf degradation [12]. Preliminary experiments on these rats
demonstrated the rescue of PRs after injection of hTf [42].
Moreover, hTf injection could be envisaged in AMD therapy,
where increased levels of chelatable iron was observed in the
RPE and Bruch’s membrane [9]. The AREDS study [43] has
already demonstrated the beneficial effect of a diet enriched
with antioxidant nutrients on the development of AMD.
Intraperitoneal administration is of particular interest,
since it highlights the therapeutic potential of Tf for protecting
iron-induced PR death in degenerative ocular diseases.
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